E-LIB Suche - Ergebnisse für: Gullo, G.

1

10MO EMPOWER-Lung 1: Cemiplimab (CEMI) monotherapy as first..:

Kilickap, S. ; Özgüroğlu, M. ; Sezer, A....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S42-S43 , 2023

Link: https://doi.org/10.1016/..

2

49P Patient-reported outcomes (PROs) in patients with advan..:

Baramidze, A. ; Gessner, C. ; Gogishvili, M....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S70-S71 , 2023

Link: https://doi.org/10.1016/..

3

75P Patient-reported outcomes (PROs) of cemiplimab + chemot..:

Baramidze, A. ; Gessner, C. ; Gogishvili, M....
Immuno-Oncology and Technology. 20 (2023) - p. 100547 , 2023

Link: https://doi.org/10.1016/..

4

P2.05-04 Pharmacokinetics of Cemiplimab in Patients With Ad..:

Papachristos, A. ; Masinde, S. ; Davis, J.D....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S308-S309 , 2023

Link: https://doi.org/10.1016/..

5

114M0 First-line cemiplimab for locally advanced non-small ..:

Kalinka, E. ; Bondarenko, I. ; Gogishvili, M....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S106 , 2023

Link: https://doi.org/10.1016/..

6

MA05.11 Predictive Utility of Patient-Reported Outcomes for..:

Gandara, D.R. ; Gogishvili, M. ; Sezer, A....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S117 , 2023

Link: https://doi.org/10.1016/..

7

P2.06-01 Cemiplimab-Based Treatment in Advanced NSCLC With ..:

Baramidze, A. ; Gessner, C. ; Gogishvili, M....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S316-S317 , 2023

Link: https://doi.org/10.1016/..

8

P2.06-10 Disease Progression on PROs in Patients With aNSCL..:

Gümüs, M. ; Kilickap, S. ; Sezer, A....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S321 , 2023

Link: https://doi.org/10.1016/..

9

50 Cemiplimab plus chemotherapy versus chemotherapy alone i..:

Makharadze, T. ; Gogishvili, M. ; Melkadze, T....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S38-S39 , 2023

Link: https://doi.org/10.1016/..

10

OA01.05 Three-year Outcomes per PD-L1 Status and Continued ..:

Garassino, M.C. ; Kilickap, S. ; Özgüroğlu, M....
Journal of Thoracic Oncology. 18 (2023) 3 - p. e2-e3 , 2023

Link: https://doi.org/10.1016/..

11

127P Phase I study of fianlimab: A human lymphocyte activat..:

Cho, B.C. ; Dy, G. ; Kim, T.M....
Immuno-Oncology and Technology. 16 (2022) - p. 100239 , 2022

Link: https://doi.org/10.1016/..

12

Patient-reported outcomes (PROs) of cemiplimab (CEMI) versu..:

Gogishvili, M. ; Kilickap, S. ; Sezer, A....
Journal of Geriatric Oncology. 13 (2022) 8 - p. S3 , 2022

Link: https://doi.org/10.1016/..

13

168P Liver metastases (mets) and treatment effect of cemipl..:

Baramidze, A. ; Gessner, C. ; Gogishvili, M....
Immuno-Oncology and Technology. 16 (2022) - p. 100280 , 2022

Link: https://doi.org/10.1016/..

14

P1.15-12 Patient-reported Outcomes of Cemiplimab versus Che..:

Kilickap, S. ; Sezer, A. ; Gümüş, M....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S125-S126 , 2022

Link: https://doi.org/10.1016/..

15

122MO Cemiplimab (cemi) + platinum doublet chemotherapy (ch..:

Baramidze, A. ; Gogishvili, M. ; Melkadze, T....
Immuno-Oncology and Technology. 16 (2022) - p. 100234 , 2022

Link: https://doi.org/10.1016/..